Healthy Living 123 (Since 2007) 健康生活123: Vitamin c administration lowers the mortality rates of critically ill patients. ❤️

Wednesday, July 10, 2019

Vitamin c administration lowers the mortality rates of critically ill patients. ❤️

Please try the new PubMed mobile website.

↓ Full text
+
Effects of different ascorbic acid doses on the mortality of critically ill patients: a meta-analysis.

Review article

Wang Y, et al. Ann Intensive Care. 2019.

Show full citation

Abstract

BACKGROUND: Low levels of ascorbic acid (AA) have been detected in critically ill patients in which AA supplementation leads to promising outcomes. However, the ability of AA to reduce mortality in critically ill patients remains controversial. In this study, we have performed a meta-analysis to evaluate the effects of AA dose on the mortality of critically ill adults.

METHODS: Electronic databases were searched for trials in which AA had been intravenously administered to critically ill patients regardless of the dose or the co-administration of antioxidant agents. The predefined primary outcome included all-cause mortality at final follow-up.

RESULTS: The included trials enrolled a total of 1210 patients. Intravenous (IV) AA doses of 3-10 g/d reduced the mortality of critically ill patients (OR 0.25; 95% CI (0.14-0.46); p < 0.001; I2 = 0.0%), while low (< 3 g/d) and high AA doses (≥ 10 g/d) had no effect (OR 1.44; 95% CI (0.79-2.61); p = 0.234; I2 = 0.0% versus OR 1.12; 95% CI (0.62-2.03); p = 0.700; I2 = 0.0%). AA was associated with a decreased duration of vasopressor support and mechanical ventilation, but did not influence fluid requirement or urine output during the first 24 h of admission. The number of patients suffering from acute kidney injury and the length of intensive care unit or hospital stays were also unaffected by the AA.

CONCLUSION: Intravenous AA reduces the duration of vasopressor support and mechanical ventilation; 3-10 g AA results in lower overall mortality rates. Given the limitations of the primary literature, further studies are required to fully clarify the effectiveness of AA during the management of critically ill patients.

PMID

31111241 []

PMCID

PMC6527630

Full text

Free PMC article

Full text at journal site

Previous Citation 6 of 5703 Back to results Next

Similar articles

Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients.

Review article

Bruder EA, et al. Cochrane Database Syst Rev. 2015.